MofCOM’s 2021 Pharma Distribution Report Shows Market Recovery
The Ministry of Commerce (MofCOM) released its annual statistical review of the pharma distribution industry...
NHSA Issues Notice on Special Treatment of Oral Implant Medical Service Charges
The National Healthcare Security Administration (NHSA) has released a Notice on “Carrying out Special Treatment...
Keymed and Lepu’s CMG901 Receives Breakthrough Therapy Designation for Gastric Cancer
The Center for Drug Evaluation (CDE) website indicates that CMG901, a Claudin 18.2 (CLDN18.2)-targeted antibody...
Realcan Pharma and AWS Expand Partnership for Digital Transformation
China-based Realcan Pharmaceutical Group Co., Ltd (SHE: 002589) and Amazon Web Services (AWS) have agreed...
Salipro Biotech Secures Patent Protection for Membrane Protein Stabilization Tech
Sweden-based Salipro Biotech AB announced that its core technology for stabilizing membrane proteins for drug...
Sirnaomics Initiates Phase I Study of STP705 for Abdominal Fat Reduction
Sino-US siRNA therapy developer Sirnaomics Ltd (HKG: 2257) has announced the first subject dosing in...
China Pharma H1 2022 Financials: 40% of Firms Report Revenue and Profit Growth
A total of 449 pharmaceutical and health-tech companies listed in China have released their H1...
Suzhou InnoBM Pharmaceuticals Raises Series A+ Funding for Tumor Immunotherapy
China-based Suzhou InnoBM Pharmaceuticals reportedly raised tens of millions of renminbi in a Series A+...
Laekna Therapeutics Doses First Patient in LAE001/LAE002 Study for Prostate Cancer
China-based Laekna Therapeutics Shanghai Co., Ltd announced that the first patient has been dosed in...
NHSA Reveals Drugs Passing Initial Review for NRDL Inclusion
The National Healthcare Security Administration (NHSA) released a notification listing the drugs that have passed...
Innovent’s Tyvyt Combo Shows PFS Benefit in EGFR-Mutant NSCLC
China-based Innovent Biologics Inc. (HKG: 1801) announced positive results from the Phase III ORIENT-31 study...
Huadong Medicine Pays EUR 105M for 35% Stake in Heidelberg Pharma
China’s Huadong Medicine Co., Ltd (SHE: 000963) announced that it has paid a total of...
CStone Pharmaceuticals Partners with Rigen Biotech on Thyroid Cancer RET Gene Testing
China-based CStone Pharmaceuticals (HKG: 2616) has entered into a partnership with Shanghai Rigen Biotech to...
Biocytogen and FineImmune Partner on Innovative Cell Therapy Drug Development
China-based Contract Research Organization (CRO) Biocytogen (Beijing) Co., Ltd has entered into a collaboration with...
CMS’s Rxilient Medical Licenses Insulin Products from Hefei Tianmai Biotech
China Medical System Holdings (CMS; HKG: 0867) announced that its subsidiary Rxilient Medical Pte. Ltd...
Kelun Pharmaceutical Receives USD 35 Million from Merck Sharp & Dohme Corp.
China-based Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) announced that it has received a USD...
Hainan Yuekang’s YK-029A Biosimilar Set for BTD in EGFR ex20ins NSCLC
The Center for Drug Evaluation (CDE) website indicates that China-based Hainan Yuekang Biological Medicine Co.,...
Walvax Biotech Enrolls First Subject in Phase III HPV Vaccine Study
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) announced the first subject enrollment for a Phase...
Sinocelltech’s Ripertamab Officially Launched in China for DLBCL Treatment
China-based Sinocelltech Group Ltd (SHA: 688520) announced the first deliveries and prescriptions of its ripertamab...
Innovent’s Tyvyt Shows PFS Benefit in EGFR-Mutant NSCLC at ESMO
China-based Innovent Biologics, Inc. (HKG: 1801) presented results of the ORIENT-31 study for its PD-1...